| (A) | ||||||||||
| Survival Probability in % (95% Confidence Interval) | ||||||||||
| Test Population | White | Black | Other | Unkown | ||||||
| n | % | n | % | n | % | n | % | n | % | |
| 5-Year Survival | ||||||||||
| All Cases | 41 | 70.7% | 33 | 75.8% | 4 | 75.0% | 4 | 25.0% | 0 | -- |
| Age at diagnosis | ||||||||||
| 0 - 19 years | 22 | 90.9% | 18 | 94.4% | 2 | 100.0% | 2 | 50.0% | 0 | -- |
| 20 - 39 years | 8 | 87.5% | 8 | 87.5% | 0 | -- | 0 | -- | 0 | -- |
| 40 - 59 years | 9 | 22.2% | 6 | 16.7% | 2 | -- | 1 | 0.0% | 0 | -- |
| >60 years | 2 | 0.0% | 1 | 0.0% | 0 | -- | 1 | 0.0% | 0 | -- |
| Sex | ||||||||||
| Male | 24 | 74.9% | 19 | 78.9% | 2 | 100.0% | 3 | 33.3% | 0 | -- |
| Female | 17 | 64.7% | 14 | 71.4% | 2 | 50.0% | 1 | 0.0% | 0 | -- |
| All phenotypes | ||||||||||
| T-cell | 12 | 91.7% | 9 | 88.9% | 2 | 100.0% | 1 | 100.0% | 0 | -- |
| B-cell | 24 | 58.2% | 20 | 65.0% | 2 | -- | 2 | 0.0% | 0 | -- |
| Unknown lineage | 5 | 80.0% | 4 | 100.0% | 0 | -- | 1 | 0.0% | 0 | -- |
| Other | 0 | -- | 0 | -- | 0 | -- | 0 | -- | 0 | -- |
| 10-Year Survival | ||||||||||
| All Cases | 41 | 64.8% | 33 | 68.5% | 4 | 75.0% | 4 | 25.0% | 0 | -- |
| Age at diagnosis | ||||||||||
| 0 - 19 years | 22 | 80.7% | 18 | 81.7% | 2 | 100.0% | 2 | 50.0% | 0 | -- |
| 20 - 39 years | 8 | 87.5% | 8 | 87.5% | 0 | -- | 0 | -- | 0 | -- |
| 40 - 59 years | 9 | 22.2% | 6 | 16.7% | 2 | -- | 1 | 0.0% | 0 | -- |
| >60 years | 2 | 0.0% | 1 | 0.0% | 0 | -- | 1 | 0.0% | 0 | -- |
| Sex | ||||||||||
| Male | 24 | 69.9% | 19 | 72.9% | 2 | 100.0% | 3 | 33.3% | 0 | -- |
| Female | 17 | 56.6% | 14 | 61.2% | 2 | -- | 1 | 0.0% | 0 | -- |
| All phenotypes | ||||||||||
| T-cell | 12 | 91.7% | 9 | 88.9% | 2 | 100.0% | 1 | 100.0% | 0 | -- |
| B-cell | 24 | 46.6% | 20 | 52.0% | 2 | -- | 2 | 0.0% | 0 | -- |
| Unknown lineage | 5 | 80.0% | 4 | 100.0% | 0 | -- | 1 | 0.0% | 0 | -- |
| Other | 0 | -- | 0 | -- | 0 | -- | 0 | -- | 0 | -- |
| (B) | ||||||||||
| Survival Probability in % (95% Confidence Interval) | ||||||||||
| Test Population | White | Black | Other | Unkown | ||||||
| n | % | n | % | n | % | n | % | n | % | |
| 5-Year Survival | ||||||||||
| All Cases | 34 | 52.9% | 28 | 53.6% | 2 | -- | 3 | 66.7% | 1 | 0.0% |
| Age at diagnosis | ||||||||||
| 0 - 19 years | 16 | 68.8% | 12 | 66.7% | 2 | -- | 2 | 100.0% | 0 | -- |
| 20 - 39 years | 5 | -- | 4 | -- | 0 | -- | 0 | -- | 1 | 0.0% |
| 40 - 59 years | 11 | 36.4% | 10 | 40.0% | 0 | -- | 1 | 0.0% | 0 | -- |
| >60 years | 2 | 50.0% | 2 | 50.0% | 0 | -- | 0 | -- | 0 | -- |